Clinical trialNCT00519194TerminatedInterventional

CONcomitant eValuation of Epicor Left atRial Therapy for AF

SponsorAbbott Medical DevicesEnrollment112Atrial Fibrillation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test the safety and efficacy of the Epicor LP Cardiac Ablation System for treating permanent atrial fibrillation during concomitant open chest and/or open heart surgery for one of more of the following procedures: mitral valve repair or replacement, aortic valve repair or replacement, tricuspid valve repair or replacement, coronary artery bypass surgery or patent foramen ovale (PFO closure).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark Groh, MD
Mission Hospitals
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

St. Agnes Medical Center
Fresno, California, United States
Blake Medical Center
Bradenton, Florida, United States
Manatee Memorial Hospital
Bradenton, Florida, United States
Cardiology Consultants, Md'S Pa (baptist Hospital)
Pensacola, Florida, United States
Northshore University Health System
Evanston, Illinois, United States
Community Hospital
Munster, Indiana, United States
Midatlanatic Cardiovascular Associates, Pa; Union Memorial Hospital
Baltimore, Maryland, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
Minneapolis Heart Institute Foundation/abbott Nw Hospital
Minneapolis, Minnesota, United States
Healtheast St. Joseph'S Hospital
Saint Paul, Minnesota, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
University of Rochester Medical Center
Rochester, New York, United States
St. Francis Hospital
Roslyn, New York, United States
Mission Hospital, Inc
Asheville, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2009
Primary completion: 31 Mar 2013
Completion: 31 Mar 2013
Last update posted: 19 Feb 2019
Registered enrollment: 112
Registry id: NCT00519194

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.